Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Axel U Dignass

43PUBLICATIONS
107CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Ngā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)Disease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)Nutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

Sort by Publication Date:
|May 20, 2026
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus.

|May 11, 2026
Mirikizumab is associated with rapid and sustained improvements in novel measures of bowel urgency in moderately-to-severely active ulcerative colitis: 28-week results from the LUCENT-URGE trial.

|Mar 27, 2026
Timing matters: recommendations for outcome assessment in real-world evidence studies of Crohn's disease.

Paula Leão Moreira, Axel Dignass, Maria Manuela Estevinho

|Mar 04, 2026
Mirikizumab four-year sustained and durable efficacy and safety in ulcerative colitis: Final findings from the LUCENT-3 open-label extension study.

Bruce E Sands, David B Clemow, Geert D'Haens

|Jul 12, 2025
Efficacy and Safety of Infliximab and Vedolizumab Maintenance Therapy in Patients with Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis.

Bruce E Sands, Laurent Peyrin-Biroulet, Stefan Schreiber

|Jun 27, 2025
Gaps between European Crohn's and Colitis Organisation quality standards of care and the real world on diagnosis and monitoring inflammatory bowel disease across Europe: results from the E-QUALITY survey.

Gionata Fiorino, Catarina Fidalgo, Michel Adamina

Pageof 8

Frequent Collaborators

11 joint publications

Jürgen Stein

8 joint publications

Ayşegül Aksan

8 joint publications

Silvio Danese

8 joint publications

Laurent Peyrin-Biroulet

6 joint publications

Fernando Magro

5 joint publications

Heinfried H Radeke

3 joint publications

Alessandro Armuzzi

3 joint publications

Julian Panés

3 joint publications

Jonas Halfvarson

3 joint publications

Taku Kobayashi

Frequent Collaborators

11 joint publications

Jürgen Stein

8 joint publications

Ayşegül Aksan

8 joint publications

Silvio Danese

8 joint publications

Laurent Peyrin-Biroulet